News

Biomune Introduces Adenomune™ II

Lenexa, KS--- Biomune Company has announced the introduction of Adenomune II for use in turkeys. The vaccine aids in the prevention of disease caused by hemorrhagic enteritis virus and is recommended for use in turkeys five weeks of age or older. The vaccine is prepared in freeze dried form for convenient storage and is administered in the drinking water.

Adenomune II provides high consistent serological titers in turkeys and each serial is subject to stringent quality control tests. The vaccine is tested to be free of other disease agents and does not pose the risk of introducing unwanted organisms. The vaccine is available in 2,000 and 5,000 dose vials.

For further information on Adenomune II call 1-800-846-0230.

Biomune is a leading U.S. manufacturer of vaccines and bacterins for the poultry industry. Since its inception in 1988, the company’s rapid growth has been marked by technology breakthroughs and new product introductions such as the world’s first licensed Salmonella enteritidis vaccines for poultry that are considered the world’s standard. The company offers a quality line of inactivated, recombinant and live vaccines in addition to custom autogenous vaccines in the combinations needed for modern poultry production. For further information on the full line of Biomune vaccine and bacterin products contact your sales representative or call 1-800-846-0230.

* * *